Back

Potentially inappropriate prescribing and its demographic and clinical correlates in older adults with atrial fibrillation: a population-based study

28 August 2022 (10:15 - 10:55)
Organised by:
Congress Presentation Part of: Anticoagulant therapy: real world use and clinical challenges Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Ms Cheima Amrouch

Ghent University, Ghent (Belgium)

4 More presentations in this session

Presentation thumbnail
Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: a nationwide cohort study
Mr M. Grymonprez (Gent, BE)
Abstract Slides
Presentation thumbnail
Oral anticoagulation in patients with atrial fibrillation and stage IV and V chronic kidney disease: a systematic review and meta-analysis
Doctor A. Miranda-Arboleda (Boston, US)
Abstract Slides
Presentation thumbnail
The real-world effectiveness and safety of edoxaban treatment in 27,333 Global ETNA-AF programme patients with and without a history of heart failure
Professor J. Siller-Matula (Vienna, AT)
Abstract Slides
Presentation thumbnail
The effect of eplerenone on the disease onset and progression of phospholamban cardiomyopathy in presymptomatic mutation carriers: results of the i-PHORECAST trial
Mr R. De Brouwer (Groningen, NL)
Abstract Slides

Access the full session

Session thumbnail
Anticoagulant therapy: real world use and clinical challenges

The Event

Event poster

ESC Congress 2022

28 August 2022 10:15 CET
You may be interested in
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
ESC TV Today
Episode 7: Coronary spasm - Sex differences in heart failure
thumbnail
Congress Session
Challenges in hypertension management

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources